63 related articles for article (PubMed ID: 11563675)
1. High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART.
Horváth A; Bánhegyi D; Bíró A; Ujhelyi E; Veres A; Horváth L; Prohászka Z; Bácsi A; Tarján V; Romics L; Horváth I; Tóth FD; Füst G; Karádi I
Immunobiology; 2001 Aug; 203(5):756-68. PubMed ID: 11563675
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of antibodies against 70 kDa heat shock proteins in the sera of patients with HIV infection.
Kocsis J; Prohászka Z; Bíró A; Füst G; Bánhegyi D
J Med Virol; 2003 Dec; 71(4):480-2. PubMed ID: 14556258
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against heat shock proteins and cholesterol in HIV infection.
Füst G; Beck Z; Bánhegyi D; Kocsis J; Bíró A; Prohászka Z
Mol Immunol; 2005 Jan; 42(1):79-85. PubMed ID: 15488946
[TBL] [Abstract][Full Text] [Related]
4. Dramatic changes in the serum levels of anti-cholesterol antibodies after eversion endarterectomy in patients with severe carotid atherosclerosis.
Bíró A; Dósa E; Horváth A; Prohászka Z; Rugonfalvi-Kiss S; Szabó A; Karádi I; Acsády G; Selmeczi L; Entz L; Füst G; Romics L
Immunol Lett; 2005 Jun; 99(1):51-6. PubMed ID: 15894111
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-cholesterol antibodies in chronic hepatitis-C patients during IFN-alpha-2b treatment.
Biró A; Horváth A; Varga L; Nemesánszky E; Csepregi A; Dávid K; Tolvaj G; Ibrányi E; Telegdy L; Pár A; Romics L; Karádi I; Horányi M; Gervain J; Ribiczey P; Csöndes M; Füst G
Immunobiology; 2003; 207(3):161-8. PubMed ID: 12777057
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
7. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
[TBL] [Abstract][Full Text] [Related]
8. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
10. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
11. Serum concentration of acute phase protein and lipid profile in HIV-1 seropositive patients and its relationship to the progression of the disease.
Ogunro PS; Idogun ES; Ogungbamigbe TO; Ajala MO; Olowu OA
Niger Postgrad Med J; 2008 Dec; 15(4):219-24. PubMed ID: 19169337
[TBL] [Abstract][Full Text] [Related]
12. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
[TBL] [Abstract][Full Text] [Related]
13. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
14. IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy.
Orsilles MA; Pieri E; Cooke P; Caula C
APMIS; 2006 Jan; 114(1):55-60. PubMed ID: 16499662
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
[TBL] [Abstract][Full Text] [Related]
16. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study.
Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Solinas P; Mannazzu M; Falchi A; Mura MS; Madeddu G
Clin Endocrinol (Oxf); 2006 Apr; 64(4):375-83. PubMed ID: 16584508
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures.
La Sala GB; Pilotti E; Nicoli A; Pinelli S; Villani MT; Ronzi P; Zendri E; Re MC; Magnani G; Casoli C
AIDS; 2007 Jan; 21(3):377-9. PubMed ID: 17255749
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
[TBL] [Abstract][Full Text] [Related]
19. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
20. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.
Floris-Moore M; Howard AA; Lo Y; Arnsten JH; Santoro N; Schoenbaum EE
HIV Med; 2006 Oct; 7(7):421-30. PubMed ID: 16925727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
